The University of Chicago Header Logo

Connection

Peter Riedell to Depsipeptides

Back to Details
This is a "connection" page, showing publications Peter Riedell has written about Depsipeptides.
Peter Riedell
Connection Strength
0.059
Depsipeptides
  1. A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas. Clin Lymphoma Myeloma Leuk. 2025 May; 25(5):328-336.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.